Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

NCT02139371 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Prostate Cancer
Urinary Bladder Cancer

Interventions

OTHER: Injection of 64Cu-DOTA-AE105

Sponsor

Rigshospitalet, Denmark